These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 2147161

  • 1. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
    Vavra N, Salzer H, Sevelda P, Breitenecker G, Czerwenka K, Kucera H.
    Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
    [Abstract] [Full Text] [Related]

  • 2. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
    Husslein P, Egarter C, Eppel W, Salzer H, Spona J.
    Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
    [Abstract] [Full Text] [Related]

  • 3. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S, Yamamoto H, Inaii H, Koyama H.
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
    [Abstract] [Full Text] [Related]

  • 4. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK, Titova VA.
    Sov Med; 1990 Nov; (9):102-7. PubMed ID: 2148437
    [No Abstract] [Full Text] [Related]

  • 5. [Adjuvant gestagen therapy in stage I endometrial cancer].
    Lahousen M, Pickel H.
    Zentralbl Gynakol; 1988 Nov; 110(16):1013-7. PubMed ID: 2973195
    [Abstract] [Full Text] [Related]

  • 6. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI.
    Vopr Onkol; 1989 Nov; 35(7):771-8. PubMed ID: 2528239
    [No Abstract] [Full Text] [Related]

  • 7. Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma.
    Riippa P, Kauppila A, Sundström H, Vihko R.
    Anticancer Res; 1984 Nov; 4(3):109-12. PubMed ID: 6235770
    [Abstract] [Full Text] [Related]

  • 8. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ, Zhang XY.
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [Abstract] [Full Text] [Related]

  • 9. A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study.
    Tveter KJ, Hagen S, Holme I, Klepp O, Kloster SE, Muri O, Poulsen C, Sander S, Sivertsen S, Urnes T.
    Scand J Urol Nephrol; 1990 May; 24(4):243-7. PubMed ID: 2148830
    [Abstract] [Full Text] [Related]

  • 10. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I, Mechl Z.
    Neoplasma; 1985 May; 32(1):119-24. PubMed ID: 3157070
    [Abstract] [Full Text] [Related]

  • 11. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E, Jouve M, Palangie T, Bretaudeau B, Asselain B, Magdelenat H, Merle S, Zajdela A, Pouillart P.
    Bull Cancer; 1984 May; 71(1):22-9. PubMed ID: 6324934
    [Abstract] [Full Text] [Related]

  • 12. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F, Martoni A, Fruet F, Strocchi E, Di Marco AR.
    Eur J Cancer (1965); 1980 May; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract] [Full Text] [Related]

  • 13. Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
    Rendina GM, Donadio C, Fabri M, Mazzoni P, Nazzicone P.
    Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):285-91. PubMed ID: 6235140
    [Abstract] [Full Text] [Related]

  • 14. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
    Mauriac L, Durand M, Bonichon F, Chauvergne J.
    Bull Cancer; 1986 Jun; 73(2):148-54. PubMed ID: 2942203
    [Abstract] [Full Text] [Related]

  • 15. [Phase II study of medroxyprogesterone acetate in advanced breast cancer].
    Ueno K, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nakamura T, Ito Y, Imajo K, Ozeki H.
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3198-202. PubMed ID: 2946264
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L, Ausilli-Cefaro GP, Turriziani A, Saccheri S, Venturo I, Minotti G.
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract] [Full Text] [Related]

  • 17. A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
    Macdonald RR, Thorogood J, Mason MK.
    Br J Obstet Gynaecol; 1988 Feb; 95(2):166-74. PubMed ID: 2964861
    [Abstract] [Full Text] [Related]

  • 18. [Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].
    Palmeri R, Papalia E, Lazzara S, Belnome NA, Gorgone S, Calbo E, Melita P.
    Chir Ital; 1987 Apr; 39(2):185-92. PubMed ID: 2958166
    [Abstract] [Full Text] [Related]

  • 19. Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients.
    Mallmann P, Dietrich K, Krebs D.
    Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):699-706. PubMed ID: 2151629
    [Abstract] [Full Text] [Related]

  • 20. Experimental combined hormone therapy on human breast carcinomas serially transplanted into nude mice.
    Fukutomi T, Kubota T, Ikeda T, Isobe Y, Kikuyama S, Shimada A, Nakamura A, Nishiumi T, Enomoto K, Ishibiki K.
    Jpn J Cancer Res; 1986 Jan; 77(1):92-7. PubMed ID: 2937762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.